Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment

Author:

Acter Shahinur1ORCID,Moreau Michele1ORCID,Ivkov Robert1,Viswanathan Akila1,Ngwa Wilfred1

Affiliation:

1. Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA

Abstract

In efforts to overcome current challenges in cancer treatment, multifunctional nanoparticles are attracting growing interest, including nanoparticles made with polydopamine (PDA). PDA is a nature-inspired polymer with a dark brown color. It has excellent biocompatibility and is biodegradable, offering a range of extraordinary inherent advantages. These include excellent drug loading capability, photothermal conversion efficiency, and adhesive properties. Though the mechanism of dopamine polymerization remains unclear, PDA has demonstrated exceptional flexibility in engineering desired morphology and size, easy and straightforward functionalization, etc. Moreover, it offers enormous potential for designing multifunctional nanomaterials for innovative approaches in cancer treatment. The aim of this work is to review studies on PDA, where the potential to develop multifunctional nanomaterials with applications in photothermal therapy has been demonstrated. Future prospects of PDA for developing applications in enhancing radiotherapy and/or immunotherapy, including for image-guided drug delivery to boost therapeutic efficacy and minimal side effects, are presented.

Funder

National Institutes of Health

Publisher

MDPI AG

Subject

General Materials Science,General Chemical Engineering

Reference117 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

2. Assessment of the evolution of cancer treatment therapies;Arruebo;Cancers,2011

3. Drug resistance and combating drug resistance in cancer;Wang;Cancer Drug Resist.,2019

4. Innovative approaches for cancer treatment: Current perspectives and new challenges;Pucci;Ecancermedicalscience,2019

5. Nanomaterials for cancer therapy: Current progress and perspectives;Cheng;J. Hematol. Oncol.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3